Literature DB >> 15511630

Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression.

Ram K Sindhu1, Ashkan Ehdaie, Nosratola D Vaziri, Christian K Roberts.   

Abstract

Chronic renal failure (CRF) has been documented to cause oxidative stress and alter nitric oxide (NO) metabolism. However, the effect of CRF on proteins related to NO bioactivity has not been investigated. The present study was designed to test the hypothesis that CRF would induce changes in caveolin-1 (Cav-1), soluble guanylate cyclase (sGC) and Akt, three proteins important in regulating NO synthase (NOS) functionality. Male Sprague-Dawley rats were randomized to CRF via 5/6 nephrectomy or sham-operated control groups. After 6 weeks, body weight, blood pressure, creatinine clearance, plasma creatinine, urinary cyclic guanosine monophosphate (cGMP) and immunodetectable levels of Cav-1, sGC and Akt were determined in the renal, aorta, heart and liver tissues from both groups. CRF resulted in marked decreases in body weight and creatinine clearance, and elevation of blood pressure and plasma creatinine. An apparent upregulation of sGC protein abundance in renal tissue was noted, with no change in aorta, heart and liver. This was accompanied by a reduction in urinary cGMP levels, indicative of sGC dysfunction. Cav-1 protein abundance was increased in aortic, liver and renal tissues. In contrast, CRF depressed Akt abundance in aorta, heart and liver tissues. These data document that CRF is characterized by alteration in the abundance of proteins regulating NO function in hepatic, vascular, cardiac and renal tissues, and a decrease in cGMP, which contributes to hypertension and changes in NO bioactivity previously noted in this model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15511630     DOI: 10.1016/j.bbadis.2004.06.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Renal caveolin-1 expression in children with unilateral ureteropelvic junction obstruction.

Authors:  Patricia G Vallés; Walter Manucha; Liliana Carrizo; José Vega Perugorria; Alicia Seltzer; Celeste Ruete
Journal:  Pediatr Nephrol       Date:  2006-11-17       Impact factor: 3.714

2.  NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy.

Authors:  Philipp Kalk; Michael Godes; Katharina Relle; Christiane Rothkegel; Andreas Hucke; Johannes-Peter Stasch; Berthold Hocher
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

Review 3.  Endothelial dysfunction: its role in hypertensive coronary disease.

Authors:  Islam Bolad; Patrice Delafontaine
Journal:  Curr Opin Cardiol       Date:  2005-07       Impact factor: 2.161

Review 4.  Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?

Authors:  Richard Van Krieken; Joan C Krepinsky
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

5.  Responsiveness of internal thoracic arteries to nitroglycerin in patients with renal failure.

Authors:  Masashi Tawa; Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki; Takaharu Ishibashi; Tomio Okamura
Journal:  Heart Vessels       Date:  2017-12-11       Impact factor: 2.037

6.  Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.

Authors:  T H Guan; G Chen; B Gao; M R Janssen; L Uttarwar; A J Ingram; J C Krepinsky
Journal:  Diabetologia       Date:  2013-06-21       Impact factor: 10.122

Review 7.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

Review 8.  Vascular effects of exercise training in CKD: current evidence and pathophysiological mechanisms.

Authors:  Amaryllis H Van Craenenbroeck; Emeline M Van Craenenbroeck; Evangelia Kouidi; Christiaan J Vrints; Marie M Couttenye; Viviane M Conraads
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 8.237

9.  Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells.

Authors:  Neel Mehta; Dan Zhang; Renzhong Li; Tony Wang; Agata Gava; Pavithra Parthasarathy; Bo Gao; Joan C Krepinsky
Journal:  Cell Commun Signal       Date:  2019-04-17       Impact factor: 5.712

10.  miR-26a Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease.

Authors:  Bin Wang; Aiqing Zhang; Haidong Wang; Janet D Klein; Lin Tan; Ze-Mu Wang; Jie Du; Nawazish Naqvi; Bi-Cheng Liu; Xiaonan H Wang
Journal:  Theranostics       Date:  2019-03-07       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.